{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:59:29Z","timestamp":1792828769416,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00066-025-02452-6","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T07:35:15Z","timestamp":1755588915000},"page":"1219-1226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Potential prognostic role of the 18F-FDG PET\/CT metabolic response in locally advanced cervical cancer after definitive chemoradiotherapy: a\u00a0narrative review"],"prefix":"10.1007","volume":"201","author":[{"given":"Lorena","family":"Draghini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edy","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Felice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Caroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Navarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Fionda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaliana","family":"De Sanctis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Vicenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"issue":"3","key":"2452_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung\u00a0H, Ferlay\u00a0J, Siegel\u00a0RL et\u00a0al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"2452_CR2","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.2174\/138161210791033950","volume":"16","author":"M Falasca","year":"2010","unstructured":"Falasca\u00a0M (2010) PI3K\/Akt signalling pathway specific inhibitors: a\u00a0novel strategy to sensitize cancer cells to anti-cancer drugs. Curr Pharm Des 16(12):1410\u20131416","journal-title":"Curr Pharm Des"},{"issue":"5","key":"2452_CR3","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1200\/JCO.2004.07.197","volume":"22","author":"PJ Eifel","year":"2004","unstructured":"Eifel\u00a0PJ, Winter\u00a0K, Morris\u00a0M et\u00a0al (2004) Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90\u201301. J\u00a0Clin Oncol 22(5):872\u2013880","journal-title":"J Clin Oncol"},{"issue":"15","key":"2452_CR4","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","volume":"340","author":"PG Rose","year":"1999","unstructured":"Rose\u00a0PG, Bundy\u00a0BN, Watkins\u00a0EB et\u00a0al (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N\u00a0Engl J Med 340(15):1144\u20131153","journal-title":"N Engl J Med"},{"issue":"1","key":"2452_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ygyno.2021.01.020","volume":"161","author":"G Bogani","year":"2021","unstructured":"Bogani\u00a0G, Sopracordevole\u00a0F, Di Donato\u00a0V et\u00a0al (2021) High-risk HPV-positive and -negative high-grade cervical dysplasia: analysis of 5\u2011year outcomes. Gynecol Oncol 161(1):173\u2013178","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2452_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00259-017-3809-y","volume":"45","author":"T Sarabhai","year":"2018","unstructured":"Sarabhai\u00a0T, Schaarschmidt\u00a0BM, Wetter\u00a0A et\u00a0al (2018) Comparison of 18F-FDG PET\/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix. Eur J Nucl Med Mol Imaging 45(1):67\u201376","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2452_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.radonc.2010.07.010","volume":"96","author":"C Haie-Meder","year":"2010","unstructured":"Haie-Meder\u00a0C, Mazeron\u00a0R, Magn\u00e9\u00a0N (2010) Clinical evidence on PET-CT for radiation therapy planning in cervix and endometrial cancers. Radiother Oncol 96:351\u2013355 5","journal-title":"Radiother Oncol"},{"issue":"2","key":"2452_CR8","doi-asserted-by":"publisher","first-page":"W192","DOI":"10.2214\/AJR.12.9830","volume":"201","author":"S Mirpour","year":"2013","unstructured":"Mirpour\u00a0S, Mhlanga\u00a0JC, Logeswaran\u00a0P et\u00a0al (2013) The role of PET\/CT in the management of cervical cancer. AJR Am J Roentgenol 201(2):W192\u2013W205","journal-title":"AJR Am J Roentgenol"},{"issue":"9","key":"2452_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s11547-019-01023-x","volume":"124","author":"L Draghini","year":"2019","unstructured":"Draghini\u00a0L, Costantini\u00a0S, Vicenzi\u00a0L et\u00a0al (2019) Positron emission tomography for staging locally advanced cervical cancer and assessing intensity modulated radiotherapy approach. Radiol Med 124(9):819\u2013825","journal-title":"Radiol Med"},{"issue":"11","key":"2452_CR10","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1136\/ijgc-2020-001676","volume":"30","author":"M De Cuypere","year":"2020","unstructured":"De Cuypere\u00a0M, Lovinfosse\u00a0P, Gennigens\u00a0C et\u00a0al (2020) Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography\/computed tomography (PET\/CT) predict survival in patients with locally advanced cervical cancer. Int J Gynecol Cancer 30(11):1705\u20131712","journal-title":"Int J Gynecol Cancer"},{"issue":"2021","key":"2452_CR11","first-page":"8874990","volume":"2","author":"S Sanei Sistani","year":"2021","unstructured":"Sanei Sistani\u00a0S, Parooie\u00a0F, Salarzaei\u00a0M (2021) Diagnostic accuracy of 18F-FDG-PET\/CT and MRI in predicting the tumor response in locally advanced cervical carcinoma treated by chemoradiotherapy: a\u00a0meta-analysis. Contrast Media Mol Imaging 2(2021):8874990","journal-title":"Contrast Media Mol Imaging"},{"key":"2452_CR12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page\u00a0MJ, McKenzie\u00a0JE, Bossuyt\u00a0PM et\u00a0al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"2","key":"2452_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ygyno.2012.08.006","volume":"127","author":"S Beriwal","year":"2012","unstructured":"Beriwal\u00a0S, Kannan\u00a0N, Sukumvanich\u00a0P et\u00a0al (2012) Complete metabolic response after definitive radiation therapy for cervical cancer: patterns and factors predicting for recurrence. Gynecol Oncol 127(2):303\u2013306","journal-title":"Gynecol Oncol"},{"issue":"8","key":"2452_CR14","doi-asserted-by":"publisher","first-page":"101774","DOI":"10.1016\/j.jogoh.2020.101774","volume":"49","author":"S Knight","year":"2020","unstructured":"Knight\u00a0S, Mancini\u00a0J, Touboul\u00a0C et\u00a0al (2020) Prognostic value of posttreatment FEDG-PET imaging following combined chemoradiation therapy in locally advanced cervical cancer. J\u00a0Gynecol Obstet Hum Reprod 49(8):101774","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"12","key":"2452_CR15","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1007\/s00259-018-4077-1","volume":"45","author":"GM Lima","year":"2018","unstructured":"Lima\u00a0GM, Matti\u00a0A, Vara\u00a0G et\u00a0al (2018) Prognostic value of posttreatment 18F-FDG PET\/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parameters. Eur J Nucl Med Mol Imaging 45(12):2139\u20132146","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"2452_CR16","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00259-018-3957-8","volume":"45","author":"FY Liu","year":"2018","unstructured":"Liu\u00a0FY, Su\u00a0TP, Wang\u00a0CC et\u00a0al (2018) Roles of posttherapy 18F-FDG PET\/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy. Eur J Nucl Med Mol Imaging 45(7):1197\u20131204","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"2452_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ijrobp.2013.07.009","volume":"87","author":"D Oh","year":"2013","unstructured":"Oh\u00a0D, Lee\u00a0JE, Huh\u00a0SJ et\u00a0al (2013) Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography\/computed tomography during concurrent chemoradiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys 87(3):549\u2013554","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2452_CR18","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.3802\/jgo.2021.32.e74","volume":"32","author":"C Onal","year":"2021","unstructured":"Onal\u00a0C, Guler\u00a0OC, Reyhan\u00a0M et\u00a0al (2021) Long-term outcomes of cervical cancer patients with complete metabolic response after definitive chemoradiotherapy. J\u00a0Gynecol Oncol 32(5):e74","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"2452_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00259-016-3537-8","volume":"44","author":"A Scarsbrook","year":"2017","unstructured":"Scarsbrook\u00a0A, Vaidyanathan\u00a0S, Chowdhury\u00a0F et\u00a0al (2017) Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging 44(4):581\u2013588","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2452_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijrobp.2011.05.053","volume":"83","author":"JK Schwarz","year":"2012","unstructured":"Schwarz\u00a0JK, Siegel\u00a0BA, Dehdashti\u00a0F et\u00a0al (2012) Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 83(1):185\u2013190","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"2452_CR21","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s00259-015-3112-8","volume":"42","author":"S Siva","year":"2015","unstructured":"Siva\u00a0S, Deb\u00a0S, Young\u00a0RJ et\u00a0al (2015) 18F\u2011FDG PET\/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a\u00a0prospective cohort of 105 women with mature survival data. Eur J Nucl Med Mol Imaging 42(12):1825\u20131832","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"2452_CR22","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/cncr.26317","volume":"118","author":"G Ferrandina","year":"2012","unstructured":"Ferrandina\u00a0G, Petrillo\u00a0M, Restaino\u00a0G et\u00a0al (2012) Can radicality of surgery be safely modulated on the basis of MRI and PET\/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? Cancer 118(2):392\u2013403","journal-title":"Cancer"},{"issue":"1","key":"2452_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/IGJ.0b013e318197f276","volume":"19","author":"S Motton","year":"2009","unstructured":"Motton\u00a0S, De Lapparent\u00a0T, Brenot-Rossi\u00a0I et\u00a0al (2009) 18 Fluoro-2deoxy-d-glucose-positron emission tomography and locally advanced cervical cancer. Int J Gynecol Cancer 19(1):8\u201312","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"2452_CR24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/IGC.0b013e3182428925","volume":"22","author":"K Vandecasteele","year":"2012","unstructured":"Vandecasteele\u00a0K, Delrue\u00a0L, Lambert\u00a0B et\u00a0al (2012) Value of magnetic resonance and 18FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a\u00a0prospective pathology-matched study. Int J Gynecol Cancer 22(4):630\u2013637","journal-title":"Int J Gynecol Cancer"},{"key":"2452_CR25","unstructured":"National Comprehensive Cancer Network (2024) NCCN Clinical Practice Guidelines in Oncology. https:\/\/www.nccn.org\/. Accessed 20 Apr 2024"},{"issue":"2","key":"2452_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00330-005-2804-z","volume":"16","author":"G Engin","year":"2006","unstructured":"Engin\u00a0G (2006) Cervical cancer: MR imaging findings before, during, and after radiation therapy. Eur Radiol 16(2):313\u2013324","journal-title":"Eur Radiol"},{"key":"2452_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.critrevonc.2017.02.019","volume":"113","author":"M Ferrari","year":"2017","unstructured":"Ferrari\u00a0M, Travaini\u00a0LL, Ciardo\u00a0D et\u00a0al (2017) Interim 18FDG PET\/CT during radiochemotherapy in the management of pelvic malignancies: a\u00a0systematic review. Crit Rev Oncol Hematol 113:28\u201342","journal-title":"Crit Rev Oncol Hematol"},{"issue":"19","key":"2452_CR28","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1001\/jama.298.19.2289","volume":"298","author":"JK Schwarz","year":"2007","unstructured":"Schwarz\u00a0JK, Siegel\u00a0BA, Dehdashti\u00a0F et\u00a0al (2007) Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA 298(19):2289\u20132295","journal-title":"JAMA"},{"issue":"1","key":"2452_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ijrobp.2012.02.056","volume":"85","author":"EA Kidd","year":"2013","unstructured":"Kidd\u00a0EA, Thomas\u00a0M, Siegel\u00a0BA et\u00a0al (2013) Changes in cervical cancer FDG uptake during chemoradiation and association with response. Int J Radiat Oncol Biol Phys 85(1):116\u2013122","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"20","key":"2452_CR30","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","volume":"385","author":"N Colombo","year":"2021","unstructured":"Colombo\u00a0N, Dubot\u00a0C, Lorusso\u00a0D, KEYNOTE-826 Investigators et\u00a0al (2021) Pembrolizumab for persistent, recurrent, or metastatic cervical cancer. N\u00a0Engl J Med 385(20):1856\u20131867","journal-title":"N Engl J Med"},{"key":"2452_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/hed.10037","volume":"24","author":"E Brun","year":"2002","unstructured":"Brun\u00a0E, Kjellen\u00a0E, Tennvall\u00a0J et\u00a0al (2002) FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24:127\u2013135","journal-title":"Head Neck"},{"key":"2452_CR32","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.2967\/jnumed.110.076224","volume":"51","author":"TS Aukema","year":"2010","unstructured":"Aukema\u00a0TS, Kappers\u00a0I, Olmos\u00a0RA et\u00a0al (2010) Is 18F-FDG PET\/CT useful for the early prediction of histopathologic response to neoadjuvant erlotinib in patients with non-small cell lung cancer? J\u00a0Nucl Med 51:1344\u20131348","journal-title":"J Nucl Med"},{"key":"2452_CR33","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/annonc\/mdn744","volume":"20","author":"P Bystrom","year":"2009","unstructured":"Bystrom\u00a0P, Berglund\u00a0A, Garske\u00a0U et\u00a0al (2009) Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-Dglucose positron emission tomography in patients with advanced colorectal cancer. Ann Oncol 20:1057\u20131061","journal-title":"Ann Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02452-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-025-02452-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02452-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:40:54Z","timestamp":1761154854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-025-02452-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2452"],"URL":"https:\/\/doi.org\/10.1007\/s00066-025-02452-6","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"29 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"L.\u00a0Draghini, S.\u00a0Costantini, E.\u00a0Ippolito, F.\u00a0De Felice, A.\u00a0Caroli, F.\u00a0Navarria, F.\u00a0Piccolo, B.\u00a0Fionda, V.\u00a0De Sanctis, G.\u00a0Macchia, and L.\u00a0Vicenzi declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All human and animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Specific national laws have been observed, too.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}